Literature DB >> 20980750

Stroke in asymptomatic Trypanosoma cruzi-infected patients.

Francisco Javier Carod-Artal1, Antonio Pedro Vargas, Thiago Falcao.   

Abstract

BACKGROUND: The knowledge about the natural history of stroke in Chagas disease is incomplete.
METHODS: Vascular risk factors and stroke subtypes of asymptomatic Trypanosoma cruzi-infected patients with no clinical evidence of heart failure were assessed. They were compared with chronic chagasic cardiomyopathy patients who suffered a stroke and with a control group of 60 T. cruzi-noninfected stroke patients. Eighty-six consecutive chagasic stroke patients (mean age: 57.4 years; 64% females) were studied.
RESULTS: 38.4% of chagasic stroke patients had asymptomatic T. cruzi infection. Smoking was more frequent in asymptomatic chagasic stroke patients (21.2 vs. 5.7%; p = 0.04). Prevalence of hypertension, diabetes and prior stroke was similar in both groups. Small-vessel infarction (15.6 vs. 3.8%) and large-vessel atherosclerosis (9.4 vs. 3.8%) were significantly more frequent in asymptomatic than in symptomatic T. cruzi-infected stroke patients (p = 0.001). Nevertheless, their frequency was even higher in T. cruzi-noninfected stroke patients (36.7 and 13.3%, respectively). Apical aneurysm (27.3%), left atrial dilatation (12.1%), left ventricle hypokinesia (9.4%) and right bundle branch block (36.4%) were also detected in asymptomatic T. cruzi-infected stroke patients.
CONCLUSIONS: Ischemic stroke may be the first manifestation of Chagas disease in asymptomatic patients with mild left ventricle dysfunction. Other noncardioembolic stroke subtypes can occur in asymptomatic T. cruzi-infected patients.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20980750     DOI: 10.1159/000320248

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  11 in total

Review 1.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

Review 2.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

3.  Ischemic stroke classification and risk of embolism in patients with Chagas disease.

Authors:  Vinícius Viana Abreu Montanaro; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Edson Marcio Negrão; Gabriel R de Freitas
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

5.  Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries.

Authors:  Joana Cortez; Rui Providência; Evelise Ramos; Cristina Valente; Jorge Seixas; Manuela Meruje; António Leitão-Marques; António Vieira
Journal:  World J Cardiol       Date:  2012-07-26

Review 6.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

7.  Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response.

Authors:  Maria-Jesus Pinazo; Elizabeth de Jesus Posada; Luis Izquierdo; Dolors Tassies; Alexandre-Ferreira Marques; Elisa de Lazzari; Edelweiss Aldasoro; Jose Muñoz; Alba Abras; Silvia Tebar; Montserrat Gallego; Igor Correia de Almeida; Joan-Carles Reverter; Joaquim Gascon
Journal:  PLoS Negl Trop Dis       Date:  2016-01-04

8.  Effect of mild aerobic training on the myocardium of mice with chronic Chagas disease.

Authors:  Emerson Preto; Nathalia Ea Lima; Lucila Simardi; Fernando Luiz Affonso Fonseca; Abílio Augusto Fragata Filho; Laura Beatriz Mesiano Maifrino
Journal:  Biologics       Date:  2015-09-23

9.  Acute Chagas disease induces cerebral microvasculopathy in mice.

Authors:  Lindice Mitie Nisimura; Vanessa Estato; Elen Mello de Souza; Patricia A Reis; Marcos Adriano Lessa; Hugo Caire Castro-Faria-Neto; Mirian Claudia de Souza Pereira; Eduardo Tibiriçá; Luciana Ribeiro Garzoni
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

10.  Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings.

Authors:  Jamary Oliveira-Filho; Jesângeli de S Dias; Pedro A P Jesus; Nestor J S B Neto; Roque Aras; Francisco J F B Reis; Karen L Furie
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.